1. Home
  2. CNTA

CNTA

Centessa Pharmaceuticals plc

Logo Centessa Pharmaceuticals plc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Founded: 2020 Country:
United Kingdom
United Kingdom
Employees: N/A City: ALTRINCHAM, CHESHIRE
Market Cap: 1.0B IPO Year: 2021
Target Price: $10.00 AVG Volume (30 days): 400.7K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.57 EPS Growth: N/A
52 Week Low/High: $3.80 - $12.45 Next Earning Date: 05-10-2024
Revenue: $6,853,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: